DirectHit® Test Panel for Breast Cancer

DirectHit Test Panel for Breast Cancer helps your doctor predict which therapy will most likely be effective for you.

DirectHit Advantage

Helps physician create individualized treatment plan
Increases likelihood of receiving effective drug treatments*
Saves money and wasted time by avoiding ineffective treatments*
Improves quality of life
Provides quick turnaround time
Approved by Medicare, Blue Cross, Blue Shield and others

*Although there are various FDA approved drugs approved for the treatment of breast cancer, an individual drug often delivers a favorable response in only 20-30% of the population tested. Therefore, predicting which drug will be the most effective for you personally is what makes DirectHit valuable.

Who is a good candidate?

Any patient who has had a breast tumor surgically removed is potentially a good candidate for the DirectHit Test Panel for Breast Cancer. However, if the patient has received extensive drug treatment since surgery, please have your physician contact our Customer Service Department at 410-633-4885, ext. 1000.

Ordering

DirectHit may only be ordered by your physician or oncologist and its cost may be covered by your insurance. Please check with your carrier.

If you think that DirectHit may be right for you, please contact Customer Service and request that a brochure be sent to you and your Health Care Professional.

Please Email: customerservice@cccdiag.com or Phone: 410-633-4885, ext. 1000 and provide the following information:

Your Health Care Provider’s Name and Address, and
Your Name and Address